TMZ: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

30 December 2024

  • curprev 09:5309:53, 30 December 2024‎ Lazy talk contribs‎ 3,311 bytes +84‎ No edit summary
  • curprev 08:2108:21, 30 December 2024‎ Lazy talk contribs‎ 3,227 bytes +3,227‎ Created page with "{{TreatmentInfo |drug_name=Temozolomide (TMZ) |overview=Temozolomide is an oral alkylating chemotherapy agent commonly used as a standard treatment for glioblastoma. It works by damaging the DNA of cancer cells, thereby inhibiting their ability to replicate and leading to cell death. |FDA_approval=Yes, FDA-approved for glioblastoma and anaplastic astrocytoma |used_for=Standard treatment for glioblastoma, often in combination with radiotherapy and as maintenance therapy |..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=TMZ"